Gradient Investments LLC Buys Shares of 23,890 Merit Medical Systems, Inc. $MMSI

Key Points

• Gradient Investments acquired 23,890 shares of Merit Medical Systems valued at approximately $1.66 million, joining a broad wave of institutional buying. Hedge funds and other institutions own 99.66% of MMSI’s outstanding shares.
• Merit Medical reported quarterly EPS of $1.19, beating estimates of $0.96, while revenue rose 9.5% year over year to $418.84 million. The company issued fiscal 2026 EPS guidance of $4.25–$4.35.
• Analysts remain positive, with eight Buy ratings and three Holds; the stock has a “Moderate Buy” consensus rating and an average price target of $100.30, above its reported $89.04 share price.

Gradient Investments LLC bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 23,890 shares of the medical instruments supplier's stock, valued at approximately $1,657,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MMSI. Wellington Management Group LLP lifted its holdings in shares of Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier's stock valued at $103,248,000 after buying an additional 980,823 shares during the last quarter. Norges Bank acquired a new position in Merit Medical Systems in the fourth quarter worth approximately $75,957,000. Iron Triangle Partners LP bought a new position in Merit Medical Systems during the fourth quarter valued at approximately $33,992,000. Champlain Investment Partners LLC bought a new position in Merit Medical Systems during the fourth quarter valued at approximately $32,359,000. Finally, Fifth Third Bancorp lifted its stake in Merit Medical Systems by 24,625.6% in the first quarter. Fifth Third Bancorp now owns 313,026 shares of the medical instruments supplier's stock valued at $21,577,000 after acquiring an additional 311,760 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Price Performance

MMSI stock opened at $89.04 on Monday. The stock has a market capitalization of $5.32 billion, a price-to-earnings ratio of 36.79, a price-to-earnings-growth ratio of 2.24 and a beta of 0.48. The company has a 50-day moving average of $72.21 and a two-hundred day moving average of $71.90. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same period in the previous year, the company posted $1.01 earnings per share. The firm's revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities research analysts anticipate that Merit Medical Systems, Inc. will post 3.81 EPS for the current year.

Analysts Set New Price Targets

Several analysts have commented on the stock. Needham & Company LLC boosted their target price on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Compass Point set a $107.00 price target on shares of Merit Medical Systems in a report on Monday, April 20th. BTIG Research lifted their price objective on shares of Merit Medical Systems from $100.00 to $105.00 and gave the company a "buy" rating in a research note on Friday, July 31st. Raymond James Financial reiterated an "outperform" rating and issued a $100.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st. Finally, Piper Sandler increased their target price on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Merit Medical Systems presently has a consensus rating of "Moderate Buy" and a consensus target price of $100.30.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source